2422 Stock Overview
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
Sichuan Kelun Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥33.95 |
52 Week High | CN¥34.64 |
52 Week Low | CN¥21.60 |
Beta | 0.043 |
1 Month Change | 14.23% |
3 Month Change | 49.63% |
1 Year Change | 6.29% |
3 Year Change | 60.07% |
5 Year Change | 22.65% |
Change since IPO | 96.47% |
Recent News & Updates
Recent updates
Shareholder Returns
2422 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 8.5% | 5.6% | 3.1% |
1Y | 6.3% | -11.0% | -13.1% |
Return vs Industry: 002422 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 002422 exceeded the CN Market which returned -13.1% over the past year.
Price Volatility
2422 volatility | |
---|---|
2422 Average Weekly Movement | 5.5% |
Pharmaceuticals Industry Average Movement | 7.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002422's share price has been volatile over the past 3 months.
Volatility Over Time: 002422's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 19,798 | Sichuan Liu | www.kelun.com |
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.
Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary
2422 fundamental statistics | |
---|---|
Market cap | CN¥54.01b |
Earnings (TTM) | CN¥2.67b |
Revenue (TTM) | CN¥22.04b |
20.2x
P/E Ratio2.5x
P/S RatioIs 2422 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2422 income statement (TTM) | |
---|---|
Revenue | CN¥22.04b |
Cost of Revenue | CN¥10.49b |
Gross Profit | CN¥11.55b |
Other Expenses | CN¥8.88b |
Earnings | CN¥2.67b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.68 |
Gross Margin | 52.41% |
Net Profit Margin | 12.11% |
Debt/Equity Ratio | 19.7% |
How did 2422 perform over the long term?
See historical performance and comparison